Wittekind Amends Renovaro Inc. Ownership Filing

Ticker: LNAI · Form: SC 13D/A · Filed: Oct 24, 2024 · CIK: 1527728

Renovaro Inc. SC 13D/A Filing Summary
FieldDetail
CompanyRenovaro Inc. (LNAI)
Form TypeSC 13D/A
Filed DateOct 24, 2024
Risk Levelmedium
Pages6
Reading Time7 min
Key Dollar Amounts$0.0001, $1.58, $1.55, $1.65, $1.63
Sentimentneutral

Sentiment: neutral

Topics: ownership-change, sec-filing, schedule-13d

Related Tickers: RENN

TL;DR

Wittekind updated his stake in Renovaro Inc. (RENN) - check the filing for details.

AI Summary

William Anderson Wittekind filed Amendment No. 18 to Schedule 13D on October 24, 2024, for Renovaro Inc. This filing indicates a change in beneficial ownership of the company's common stock. The filing does not specify the exact number of shares or the percentage of ownership change in this amendment.

Why It Matters

Changes in beneficial ownership filings like this can signal shifts in control or significant investment activity, potentially impacting the stock price and investor sentiment.

Risk Assessment

Risk Level: medium — Schedule 13D filings, especially amendments, often indicate significant changes in a major shareholder's position, which can lead to volatility.

Key Players & Entities

  • William Anderson Wittekind (person) — Filing party and beneficial owner
  • Renovaro Inc. (company) — Subject company
  • McCloskey Law PLLC (company) — Legal counsel for filing party

FAQ

What is the CUSIP number for Renovaro Inc. common stock?

The CUSIP number for Renovaro Inc. common stock is 29350E 104.

What is the filing date of this amendment?

The filing date of Amendment No. 18 is October 24, 2024.

Who is the subject company?

The subject company is Renovaro Inc.

Who is the primary filer for this Schedule 13D/A?

William Anderson Wittekind is the primary filer.

What is the former name of Renovaro Inc. mentioned in the filing?

Former names mentioned include RENOVARO BIOSCIENCES INC. and Enochian Biosciences Inc.

Filing Stats: 1,797 words · 7 min read · ~6 pages · Grade level 7.7 · Accepted 2024-10-24 08:57:01

Key Financial Figures

  • $0.0001 — ame of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 29350
  • $1.58 — Price Price Range 06/14/24 50,000 $1.58 $1.55-$1.65 06/25/24 20,000 $1.58
  • $1.55 — Price Range 06/14/24 50,000 $1.58 $1.55-$1.65 06/25/24 20,000 $1.58 $1.55-
  • $1.65 — Range 06/14/24 50,000 $1.58 $1.55-$1.65 06/25/24 20,000 $1.58 $1.55-$1.63
  • $1.63 — -$1.65 06/25/24 20,000 $1.58 $1.55-$1.63 06/26/24 50,000 $1.57 $1.55-$1.59
  • $1.57 — $1.58 $1.55-$1.63 06/26/24 50,000 $1.57 $1.55-$1.59 06/27/24 14,671 $1.50*
  • $1.59 — -$1.63 06/26/24 50,000 $1.57 $1.55-$1.59 06/27/24 14,671 $1.50* N/A 07/01
  • $1.50 — $1.57 $1.55-$1.59 06/27/24 14,671 $1.50* N/A 07/01/24 60,000 $1.56 $1.55-
  • $1.56 — 14,671 $1.50* N/A 07/01/24 60,000 $1.56 $1.55-$1.61 07/02/24 34,553 $1.54
  • $1.61 — * N/A 07/01/24 60,000 $1.56 $1.55-$1.61 07/02/24 34,553 $1.54 $1.50-$1.57
  • $1.54 — $1.56 $1.55-$1.61 07/02/24 34,553 $1.54 $1.50-$1.57 07/03/24 50,000 $1.51
  • $1.51 — $1.54 $1.50-$1.57 07/03/24 50,000 $1.51 $1.50-$1.58 07/05/24 60,000 $1.55
  • $1.53 — $1.55 $1.50-$1.63 07/09/24 4,630 $1.53 $1.52-$1.57 07/10/24 75,000 $1.51
  • $1.52 — $1.50-$1.63 07/09/24 4,630 $1.53 $1.52-$1.57 07/10/24 75,000 $1.51 $1.50-
  • $1.41 — $1.51 $1.50-$1.53 07/15/24 21,954 $1.41 $1.40-$1.44 07/17/24 16,362 $1.46

Filing Documents

Purpose of Transaction

Item 4. Purpose of Transaction The information in Item 6 of this Amendment No. 18 is hereby incorporated by reference into this Item 4.

Interests in Securities

Item 5. Interests in Securities of the Issuer (a)-(b) The information in Items 7-11 and Item 13 of the cover page of this Amendment No. 18, including the accompanying footnotes, is hereby incorporated by reference into this Item 5. (c) Weird Science sold the shares of Common Stock listed below, on the dates listed below, at the weighted average prices and within the price ranges listed below in brokers’ transactions pursuant to Rule 144. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range. 4 Date Number of Shares Weighted Average Price Price Range 06/14/24 50,000 $1.58 $1.55-$1.65 06/25/24 20,000 $1.58 $1.55-$1.63 06/26/24 50,000 $1.57 $1.55-$1.59 06/27/24 14,671 $1.50* N/A 07/01/24 60,000 $1.56 $1.55-$1.61 07/02/24 34,553 $1.54 $1.50-$1.57 07/03/24 50,000 $1.51 $1.50-$1.58 07/05/24 60,000 $1.55 $1.50-$1.63 07/09/24 4,630 $1.53 $1.52-$1.57 07/10/24 75,000 $1.51 $1.50-$1.57 07/11/24 14,896 $1.51 $1.50-$1.53 07/15/24 21,954 $1.41 $1.40-$1.44 07/17/24 16,362 $1.46 $1.45-$1.51 07/29/24 1,114 $1.30 $1.30-$1.31 * Actual price, not a weighted average price. (d) Not applicable. (e) Not applicable.

. Contracts, Arrangements, Understandings

Item 6 . Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. First Amended Stockholder Derivative Complaint On October 22, 2024 legal counsel for Wittekind and Weird Science filed a Notice of Subsequent Event Related to Pending Motion to Dismiss (the “ Notice of Subsequent Event ”) with the United matters disclosed in the Issuer’s Form 8-K filed on October 16, 2024 and is attached to this Amendment No. 18 as Exhibit 26. The Board Defendants filed a motion to dismiss the First Amended Stockholder Derivative Complaint on July 29, 2024. As referenced in the Notice of Subsequent Event, the motion has been fully briefed, the court held a hearing on the motion on October 3, 2024 and took the matter under submission. Amended Investor Rights Complaint On June 7, 2024 Weird Science and Wittekind (in his individual capacity as sole trustee of the Trusts) filed oppositions to the Issuer’s and the other defendants’ motions to dismiss the Amended Investor Rights Complaint. The Issuer and the other defendants filed replies to such oppositions on August 30, 2024 and oral arguments on the motions to dismiss are scheduled in the Delaware Court of Chancery on November 15, 2024. Issuer Complaint On June 21, 2024 the Issuer filed a complaint against Weird Science, Wittekind, the Trusts and Gumrukcu in the Delaware Court of Chancery alleging fraudulent concealment, equitable fraud, unjust enrichment and civil conspiracy in connection with the Merger Agreement. Among other remedies, the Issuer is seeking recovery of the shares of Common Stock issued under the Merger Agreement that are in the possession, custody or control of the defendants. The Reporting Person believes this action has no merit whatsoever, denies the allegations and intends to vigorously defend again

Material

Item 7. Material to be Filed as Exhibits Exhibit 26 Notice of Subsequent Event Related to Pending Motion to Dismiss filed with the United States District Court for the Central District of California–Western Division, on October 22, 2024. 6 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Amendment No. 18 is true, complete and correct. Date: October 23, 2024 /s/ William Anderson Wittekind WILLIAM ANDERSON WITTEKIND 7

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.